L&K Biomed Ltd. (KOSDAQ:156100)

L&K Biomed Revenue

L&K Biomed had revenue of 10.10B KRW in the quarter ending September 30, 2025, with 3.59% growth. This brings the company's revenue in the last twelve months to 40.33B, up 21.55% year-over-year. In the year 2024, L&K Biomed had annual revenue of 36.09B with 20.69% growth.

• Revenue (ttm): 40.33B
• Revenue Growth: +21.55%
• P/S Ratio: 7.26
• Revenue / Employee: 420.16M
• Employees: 60
• Market Cap: 292.98B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	36.09B	6.19B	20.69%
Dec 31, 2023	29.90B	10.14B	51.28%
Dec 31, 2022	19.77B	4.39B	28.59%
Dec 31, 2021	15.37B	-3.98B	-20.58%
Dec 31, 2020	19.36B	-7.22B	-27.16%